Internal Medicine, Endocrinology, Diabetes, & Metabolism · Freehold, NJ
NPI
1831174739
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
555 Iron Bridge Rd, Suite 18
Freehold, NJ, 07728
Phone (732) 409-6233
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
3,157 services
Medicare patients, 2024
621
Average age 74
Drug cost, 2024
$2.7M
6,411 prescriptions
Company payments, 2025
$12K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa G Young was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,231 times for 537 patients. In total Melissa G Young billed 3,157 services in 19 codes, and Medicare paid $191K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,231 | 537 | $12.63 | $16K |
| 99214 Office E&M - Established | Office | 903 | 440 | $94.35 | $85K |
| 99215 Office E&M - Established | Office | 407 | 141 | $143.33 | $58K |
| 95251 Test - Miscellaneous | Office | 284 | 99 | $27.96 | $7,940 |
| 99232 Hospital E&M - Subsequent | Facility | 198 | 33 | $64.91 | $13K |
| 99222 Hospital E&M - Initial | Facility | 47 | 38 | $105.89 | $4,977 |
| 99213 Office E&M - Established | Office | 26 | 25 | $71.13 | $1,849 |
| 76536 Ultrasound - Nonspecific | Office | 18 | 18 | $95.15 | $1,713 |
| 99204 Office E&M - New | Office | 12 | 12 | $117.97 | $1,416 |
By year: 2022 $176K for 1,946 services; 2023 $163K for 1,765 services; 2024 $191K for 3,157 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 13 | 12 | $3.21 | $41.73 |
| 83036 Blood Count | 11 | 11 | $9.52 | $105 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa G Young prescribed most often to Medicare patients was Levothyroxine Sodium, with 636 prescriptions and refills. In total Melissa G Young wrote 6,411 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 636 | 1,865 | 168 | $7,348 |
| Synthroid Levothyroxine Sodium | 479 | 1,331 | 117 | $48K |
| Metformin Hcl Generic | 458 | 1,327 | 129 | $4,562 |
| Glimepiride Generic | 404 | 1,170 | 109 | $4,993 |
| Ozempic Semaglutide | 345 | 775 | 86 | $720K |
| Metformin Hcl Er Metformin Hcl | 322 | 916 | 85 | $5,231 |
| Jardiance Empagliflozin | 223 | 533 | 58 | $293K |
| Pioglitazone Hcl Generic | 186 | 542 | 54 | $2,014 |
| Atorvastatin Calcium Generic | 178 | 526 | 50 | $2,205 |
| Rosuvastatin Calcium Generic | 146 | 432 | 44 | $2,075 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 140 | 398 | 53 | $15K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 136 | 439 | 54 | $25K |
| Farxiga Dapagliflozin Propanediol | 106 | 279 | 29 | $146K |
| Methimazole Generic | 93 | 259 | 25 | $1,381 |
| Novolog Flexpen Insulin Aspart | 92 | 219 | 33 | $26K |
Brand drugs: 2,818 claims; generic drugs: 3,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa G Young $12K ($12K in general payments such as food, travel and fees) from 19 companies. The largest payer was Sanofi-Aventis U.S. LLC with $11K.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 5 | $11K |
| Novo Nordisk Inc NVO | 16 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39.72 |
| Abbott Laboratories ABT | 2 | $31.35 |
| Insulet Corporation PODD | 2 | $29.73 |
| Xeris Pharmaceuticals, Inc. | 2 | $29.06 |
| Almatica Pharma LLC | 2 | $28.56 |
| Beta Bionics, Inc. BBNX | 1 | $21.71 |
| Lilly USA, LLC LLY | 1 | $18.84 |
| Madrigal Pharmaceuticals MDGL | 1 | $17.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.